Results 231 to 240 of about 122,299 (311)

In heart failure, echocardiographic parameters of right ventricular function are powerful tools to predict renal failure

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 2310-2320, June 2025.
Abstract Background Chronic kidney disease (CKD) has a high prevalence in patients with heart failure (HF) and is associated with prolonged hospitalization, increased need for intensive care and mortality. There is an urgent need to identify factors that influence the interaction between heart and kidney disorders, often described as cardiorenal ...
Alexander Reinecke   +7 more
wiley   +1 more source

Long‐term outcomes of apixaban as main anticoagulant in patients with HeartMate 3 left ventricular assist devices

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 1714-1718, June 2025.
Abstract Aims HeartMate 3 (HM3) left ventricular assist devices (LVADs) offer improved haemocompatibility‐related outcomes for end‐stage heart failure patients, facilitating the exploration of alternative anticoagulation therapies beyond warfarin.
Jennifer Jdaidani   +7 more
wiley   +1 more source

Managing an effective system for retrieving IVC filters: outcomes of a prospective patient database, 2012-2023. [PDF]

open access: yesCVIR Endovasc
Matsumoto MM   +5 more
europepmc   +1 more source

A Case of Surgery for Myxoma in the Inferior Vena Cava Using Deep Hypothermic Circulatory Arrest. [PDF]

open access: yesAnn Vasc Dis
Hayama M   +13 more
europepmc   +1 more source

Predicting right ventricular failure after left ventricular assist device implant: A novel approach

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 1916-1931, June 2025.
Abstract Aims Right ventricular (RV) failure (RVF) after left ventricular assist device (LVAD) implant is an important cause of morbidity and mortality. Modern, data‐driven approaches for defining and predicting RVF have been under‐utilized. Methods Two hundred thirty‐two patients were identified with a mean age of 55 years; 40 (17%) were women, 132 ...
Carissa E. Livingston   +6 more
wiley   +1 more source

Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 2023-2033, June 2025.
Abstract Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure. We aimed to evaluate the impact on a worsening renal function (WRF) by adding DAPA as compared to standard decongestive therapy with loop diuretics alone.
Shodai Kawanami   +11 more
wiley   +1 more source

Right ventricular dysfunction for prediction of long‐term recovery in de novo HFrEF : a PROLONG‐II substudy

open access: yesESC Heart Failure, Volume 12, Issue 3, Page 2166-2176, June 2025.
Abstract Aims To analyse the predictive value of advanced markers of right ventricular (RV) function and RV‐pulmonary arterial (PA) coupling in forecasting long‐term left ventricular (LV) improvement in de novo heart failure with reduced ejection fraction (HFrEF).
Aiste Monika Jakstaite   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy